|
HY-126390-1mg
|
MedChemexpress LLC
|
(E/Z)-BCI [CAS 15982-84-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-18956-2mg
|
MedChemexpress LLC
|
(E/Z)-Icerguastat [CAS 13098-73-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-N4226-1g
|
MedChemexpress LLC
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid [CAS 3719-45-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N4226-500mg
|
MedChemexpress LLC
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid [CAS 3719-45-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N4226-1mL
|
MedChemexpress LLC
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid [CAS 3719-45-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N6663-100mg
|
MedChemexpress LLC
|
3-Carene [CAS 13466-78-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6663-50mg
|
MedChemexpress LLC
|
3-Carene [CAS 13466-78-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-108547-10mg
|
MedChemexpress LLC
|
Alexidine (dihydrochloride) [CAS 1715-30-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108547-100mg
|
MedChemexpress LLC
|
Alexidine (dihydrochloride) [CAS 1715-30-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108547-250mg
|
MedChemexpress LLC
|
Alexidine (dihydrochloride) [CAS 1715-30-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108547-5mg
|
MedChemexpress LLC
|
Alexidine (dihydrochloride) [CAS 1715-30-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108547-50mg
|
MedChemexpress LLC
|
Alexidine (dihydrochloride) [CAS 1715-30-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108547-1mL
|
MedChemexpress LLC
|
Alexidine (dihydrochloride) [CAS 1715-30-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-133987-10mg
|
MedChemexpress LLC
|
AP-1/NF-Kappa B activation inhibitor 1 [CAS 188936-12-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-133987-100mg
|
MedChemexpress LLC
|
AP-1/NF-Kappa B activation inhibitor 1 [CAS 188936-12-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-133987-25mg
|
MedChemexpress LLC
|
AP-1/NF-Kappa B activation inhibitor 1 [CAS 188936-12-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-133987-5mg
|
MedChemexpress LLC
|
AP-1/NF-Kappa B activation inhibitor 1 [CAS 188936-12-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-133987-50mg
|
MedChemexpress LLC
|
AP-1/NF-Kappa B activation inhibitor 1 [CAS 188936-12-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-133987-1mL
|
MedChemexpress LLC
|
AP-1/NF-Kappa B activation inhibitor 1 [CAS 188936-12-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-136268-1mg
|
MedChemexpress LLC
|
AQX-435 [CAS 1619983-52-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-136268-10mg
|
MedChemexpress LLC
|
AQX-435 [CAS 1619983-52-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-136268-5mg
|
MedChemexpress LLC
|
AQX-435 [CAS 1619983-52-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-115502A-1mg
|
MedChemexpress LLC
|
BCI (hydrochloride) [CAS 95130-23-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-115502A-10mg
|
MedChemexpress LLC
|
BCI (hydrochloride) [CAS 95130-23-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-115502A-100mg
|
MedChemexpress LLC
|
BCI (hydrochloride) [CAS 95130-23-7]
|
|
COVID-19-immunoregulation
|
|
